TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35810043

Group type: EXPERIMENTAL
Intervention: 2.7 mm variable‐angle locking lateral calcaneal plate (Group 1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 2.7 mm variable‐angle locking anterolateral calcaneal plate with one 4.5 mm and one 6.5 mm cannulated screws (Group 2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Interlocking calcaneal nail with 3.5 mm screws and three separate 4.0 mm cannulated screws (Group 3)
Number of subjects: 18
Study: 32666858

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 327
Study: 34511585

Group type: EXPERIMENTAL
Intervention: Lumbar-type hybrid assistive limb (HAL) during sit-to-stand exercise
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-HAL during sit-to-stand exercise
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both HAL and non-HAL groups during sit-to-stand exercise
Number of subjects: 28
Study: 34569552

Group type: EXPERIMENTAL
Intervention: Counter-irrigation technique (Group A)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard technique (Group B)
Number of subjects: 48
Study: 34454995

Group type: EXPERIMENTAL
Intervention: SIRT+sorafenib
Number of subjects: 282

Group type: COMPARATOR
Intervention: sorafenib alone
Number of subjects: 282
Study: 33119142

Group type: EXPERIMENTAL
Intervention: Personal Patient Profile‐Prostate (P3P)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 295
Study: 32573058

Group type: EXPERIMENTAL
Intervention: EBNA1+ NPC cells
Number of subjects: 0
Study: 616873944

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy with stent retrievers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flow-diverting stents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting with embolic protection and plaque imaging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical management with interventional therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management alone
Number of subjects: 0
Study: 35256247

Group type: EXPERIMENTAL
Intervention: Damask rose aromatherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (paraffin oil)
Number of subjects: 80
Study: 34694643

Group type: EXPERIMENTAL
Intervention: Tendoscopic peritendon shaving
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo tendoscopic treatment
Number of subjects: 23
Study: 32844909

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation physiotherapy applied three times a day starting gait training on the first day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard physiotherapy applied once a day starting gait training on the second or third day
Number of subjects: 48
Study: 34555263

Group type: EXPERIMENTAL
Intervention: Hysterectomy with conservation of one or both adnexa
Number of subjects: 202506

Group type: COMPARATOR
Intervention: Intact uterus
Number of subjects: 202506

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 202506
Study: 35596020

Group type: EXPERIMENTAL
Intervention: Mailouts plus telephone support
Number of subjects: 497

Group type: COMPARATOR
Intervention: Mailouts alone
Number of subjects: 497
Study: 33220329

Group type: EXPERIMENTAL
Intervention: 12 g MCT/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 18 g MCT/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (0 g MCT/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MCT (12 g and 18 g)
Number of subjects: 30
Study: 32002593

Group type: EXPERIMENTAL
Intervention: 1 mg adrenaline via intraosseous route
Number of subjects: 7317

Group type: EXPERIMENTAL
Intervention: 1 mg adrenaline via intravenous route
Number of subjects: 7317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7317
Study: 34462921

Group type: EXPERIMENTAL
Intervention: Intermittent feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous feeding
Number of subjects: 0
Study: 34489390

Group type: EXPERIMENTAL
Intervention: Extended-field IMRT with chemotherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Pelvic-field IMRT with chemotherapy
Number of subjects: 34
Study: 36171582

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 200 mg daily, vitamin C 2 g every 6 hours, thiamine 200 mg every 12 hours
Number of subjects: 408

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Hydrocortisone, vitamin C, thiamine
Number of subjects: 408

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 408
Study: 34539786

Group type: EXPERIMENTAL
Intervention: CM‐LOC attachment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ball attachment
Number of subjects: 80
Study: 33185364

Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 0.1 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 0.2 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 0.4 mg
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 32444056

Group type: COMPARATOR
Intervention: Diphenhydramine solution (DS)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Diphenhydramine-containing glycyrrhiza glabra (DSG)
Number of subjects: 70
Study: 36089706

Group type: EXPERIMENTAL
Intervention: Laparoscopic approach of tunica vaginalis
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional open surgery
Number of subjects: 80
Study: 32515694

Group type: EXPERIMENTAL
Intervention: PIV ≤ 7 mL (25th percentile)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: PIV ≥ 72 mL (75th percentile)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Pre-treatment factors for small-PIV/mRS ≥ 3
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Post-treatment factors for small-PIV/mRS ≥ 3
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Factors for large-PIV/mRS ≤ 2
Number of subjects: 315
Study: 35882541

Group type: EXPERIMENTAL
Intervention: RSV
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: hMPV
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: hRV/EV
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Parainfluenza
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Atypical bacterial pathogens
Number of subjects: 931
Study: 32795561

Group type: EXPERIMENTAL
Intervention: Liuzijue Qigong combined with conventional rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional respiratory training combined with conventional rehabilitation training
Number of subjects: 60
Study: 32859308

Group type: EXPERIMENTAL
Intervention: 2019 ESPEN guidelines
Number of subjects: 152

Group type: COMPARATOR
Intervention: 2016 ASPEN guidelines
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (ESPEN)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Enteral nutrition (ASPEN)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (ESPEN)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Parenteral nutrition (ASPEN)
Number of subjects: 152
Study: 35778995

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) using ropivacaine, epinephrine, ketorolac, and normal saline solution.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Interscalene block using liposomal bupivacaine.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Interscalene block
Number of subjects: 74
Study: 33944875

Group type: EXPERIMENTAL
Intervention: Half-dose csDMARDs (n=80)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Stable-dose csDMARDs (n=80)
Number of subjects: 160
Study: 32674098

Group type: EXPERIMENTAL
Intervention: General Anesthesia
Number of subjects: 25

Group type: COMPARATOR
Intervention: Spinal Anesthesia
Number of subjects: 25
Study: 35342718

Group type: EXPERIMENTAL
Intervention: Internet-based program integrating animated psychoeducational videos, group discussion, and SGM youth help-seeking brochure.
Number of subjects: 0
Study: 35986131

Group type: EXPERIMENTAL
Intervention: High dose of Mothers and Babies (MB) intervention (attendance at >50% of MB sessions)
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Higher dose of Mothers and Babies (MB) intervention
Number of subjects: 679
Study: 32379487

Group type: COMPARATOR
Intervention: 1-Hz rTMS
Number of subjects: 31

Group type: COMPARATOR
Intervention: 10-Hz rTMS
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sham rTMS
Number of subjects: 31
Study: 35533029

Group type: EXPERIMENTAL
Intervention: Sulfonylureas
Number of subjects: 932

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 932
Study: 34507861

Group type: EXPERIMENTAL
Intervention: V114
Number of subjects: 1202

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1202
Study: 32707159

Group type: EXPERIMENTAL
Intervention: Cephalic-phase microvascular response stimulation (CP group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy subjects (CP control group)
Number of subjects: 30
Study: 36292091

Group type: EXPERIMENTAL
Intervention: Advanced Platelet-Rich Fibrin (A-PRF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Factor-Enriched Bone Graft Matrix with Advanced Platelet-Rich Fibrin (A/S-PRF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Freeze-Dried Bone Allograft and Crosslinked Collagen Membrane (FDBA/CM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resorbable Collagen Plug (RCP)
Number of subjects: 18
Study: 33438072

Group type: EXPERIMENTAL
Intervention: Vitamin C (1 g per day for 40 days)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group (without vitamin C)
Number of subjects: 292
Study: 32641023

Group type: EXPERIMENTAL
Intervention: General practitioner-based follow-up care
Number of subjects: 390

Group type: COMPARATOR
Intervention: Specialist-based follow-up care (usual care)
Number of subjects: 390
Study: 34559946

Group type: EXPERIMENTAL
Intervention: Sedentary time (ST)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Placental FATP2 expression
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Cord blood leptin
Number of subjects: 112
Study: 32912614

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined metformin and clomiphene citrate
Number of subjects: 0
Study: 36214216

Group type: EXPERIMENTAL
Intervention: 225 mg ensovibep
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 600 mg ensovibep
Number of subjects: 12
Study: 33721561

Group type: EXPERIMENTAL
Intervention: No chemotherapy (n=644)
Number of subjects: 6693

Group type: EXPERIMENTAL
Intervention: Chemotherapy (n=749)
Number of subjects: 6693

Group type: COMPARATOR
Intervention: No chemotherapy (n=748)
Number of subjects: 6693

Group type: EXPERIMENTAL
Intervention: Chemotherapy in women aged ≤50 years (n=464)
Number of subjects: 6693

Group type: COMPARATOR
Intervention: No chemotherapy in women aged ≤50 years (n=464)
Number of subjects: 6693

Group type: EXPERIMENTAL
Intervention: Chemotherapy in women aged >50 years (n=894)
Number of subjects: 6693

Group type: COMPARATOR
Intervention: No chemotherapy in women aged >50 years (n=894)
Number of subjects: 6693

Group type: EXPERIMENTAL
Intervention: Chemotherapy in node-negative patients (n=699)
Number of subjects: 6693

Group type: COMPARATOR
Intervention: No chemotherapy in node-negative patients (n=699)
Number of subjects: 6693

Group type: EXPERIMENTAL
Intervention: Chemotherapy in patients with 1-3 positive nodes (n=658)
Number of subjects: 6693

Group type: COMPARATOR
Intervention: No chemotherapy in patients with 1-3 positive nodes (n=658)
Number of subjects: 6693
Study: 33144321

Group type: EXPERIMENTAL
Intervention: S protein native trimer
Number of subjects: 578

Group type: COMPARATOR
Intervention: N protein assays
Number of subjects: 578

Group type: COMPARATOR
Intervention: S protein assays
Number of subjects: 578

Group type: COMPARATOR
Intervention: Anti-N antibodies
Number of subjects: 578
Study: 32404126

Group type: EXPERIMENTAL
Intervention: Solution Focused Brief Therapy (SFBT), 2-4 sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Solution Focused Brief Therapy (SFBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 0
Study: 35770580

Group type: EXPERIMENTAL
Intervention: Ear acupuncture combined with dry cupping
Number of subjects: 198

Group type: COMPARATOR
Intervention: Ear acupuncture
Number of subjects: 198
Study: 33438238

Group type: EXPERIMENTAL
Intervention: Biological determinist message
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Interactionist message
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (unrelated article)
Number of subjects: 174
Study: 32530781

Group type: EXPERIMENTAL
Intervention: TLC-NOSF dressings (UrgoStart Plus Pad and UrgoStart Plus Border)
Number of subjects: 1140
Study: 35330830

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.2 mg/h for 120 h)
Number of subjects: 167

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Neostigmine arm
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Neostigmine arm and Control arm
Number of subjects: 167
Study: 35863686

Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy
Number of subjects: 3059
Study: 32990529

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dry Needling with Intramuscular Electrical Stimulation (DN/IMES)
Number of subjects: 45
Study: 32048316

Group type: EXPERIMENTAL
Intervention: Nurse-led supportive intervention, details on dosage and duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (Control group).
Number of subjects: 0
Study: 32971161

Group type: EXPERIMENTAL
Intervention: 500 mg of celery seed, 3 times a day for 6 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo, 3 times a day for 6 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 500 mg of celery seed
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32700666

Group type: EXPERIMENTAL
Intervention: Sustained indoor residual spraying (IRS) of insecticide since December 2014
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Sustained indoor residual spraying (IRS) of insecticide
Number of subjects: 531
Study: 35442813

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Psychoeducation Program (PEP)
Number of subjects: 52
Study: 33592577

Group type: EXPERIMENTAL
Intervention: 3 valid days of accelerometer wear
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: 2 valid days of accelerometer wear
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: 1 valid day of accelerometer wear
Number of subjects: 159

Group type: COMPARATOR
Intervention: ≥4 valid days of accelerometer wear (criterion)
Number of subjects: 159
Study: 32801696

Group type: EXPERIMENTAL
Intervention: Dimethicone nanoemulsions (DMNs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional dimethicone emulsions
Number of subjects: 0
Study: 35852035

Group type: EXPERIMENTAL
Intervention: Hypothermic dialysis (35.5°C)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine dialysis (36.5°C)
Number of subjects: 45
Study: 33903890

Group type: EXPERIMENTAL
Intervention: Single hyperbaric oxygen treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait condition (Control)
Number of subjects: 60
Study: 33858378

Group type: EXPERIMENTAL
Intervention: Clinical metagenomics assay
Number of subjects: 159
Study: 32885585

Group type: EXPERIMENTAL
Intervention: Vitamin E 1500 IU/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metformin 500 mg thrice daily + 150 mg/day CC for 5 days
Number of subjects: 60
Study: 32308903

Group type: EXPERIMENTAL
Intervention: Noninvasive vagal nerve stimulation (n‐VNS)
Number of subjects: 24
Study: 34677755

Group type: EXPERIMENTAL
Intervention: WHO Caregiver Skills Training (CST)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual
Number of subjects: 86
Study: 34670665

Group type: EXPERIMENTAL
Intervention: Cisplatin (DDP) at IC50 (3.586 mg/L) for 48 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisplatin (DDP) at IC50 (3.586 mg/L) combined with 20 μmol/L PD98059 for 48 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20 μmol/L PD98059 for 48 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 0
Study: 33217219

Group type: EXPERIMENTAL
Intervention: Genomics-assisted prediction model based on QTLs and KASP markers
Number of subjects: 9422

Group type: EXPERIMENTAL
Intervention: MdMYB1 marker H162
Number of subjects: 9422
Study: 34881557

Group type: EXPERIMENTAL
Intervention: Tai chi intervention for 12 weeks
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group with normal dietary and exercise habits
Number of subjects: 99
Study: 32252822

Group type: EXPERIMENTAL
Intervention: Mat Pilates
Number of subjects: 42

Group type: COMPARATOR
Intervention: Aquatic aerobic exercise
Number of subjects: 42
Study: 33099054

Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 113
Study: 32019123

Group type: EXPERIMENTAL
Intervention: Women with GDM
Number of subjects: 1031

Group type: COMPARATOR
Intervention: Women without GDM
Number of subjects: 1031
Study: 34705196

Group type: EXPERIMENTAL
Intervention: WeChat-based multimodal psychoeducational intervention (ICARE programme)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 33563147

Group type: EXPERIMENTAL
Intervention: Pharmacotherapies that increase HDL-C concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma HDL-C concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidemiological studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies and genome-wide association studies
Number of subjects: 0
Study: 32862232

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study: 35817294

Group type: EXPERIMENTAL
Intervention: Dyadic CARE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supporter-only CARE
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 33512028

Group type: EXPERIMENTAL
Intervention: Structured group intervention based on pain neuroscience education (PNE) - 7 group sessions of education in neurobiology of pain
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Structured group intervention based on pain neuroscience education (PNE)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 139
Study: 34942135

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg/day orally)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 33484874

Group type: EXPERIMENTAL
Intervention: 100 mW red laser irradiation
Number of subjects: 10
Study: 33726841

Group type: EXPERIMENTAL
Intervention: MEDPass administration of ONS (50 ml four times per day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional administration of ONS (between meals)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: MEDPass administration of ONS
Number of subjects: 200
Study: 35967549

Group type: EXPERIMENTAL
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Nasal Intermittent Positive Pressure Ventilation (NIPPV)
Number of subjects: 960
Study: 33094860

Group type: EXPERIMENTAL
Intervention: Open weighing (sharing weight data with patients)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Blind weighing (not sharing weight data with patients)
Number of subjects: 216
Study: 35112592

Group type: EXPERIMENTAL
Intervention: Preoperative home chest physiotherapy program for one week in addition to the traditional postoperative program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional postoperative program only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preoperative home chest physiotherapy program
Number of subjects: 100
Study: 34238381

Group type: EXPERIMENTAL
Intervention: SLC45A2 rs28777-A allele
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: SLC45A2 rs183671-G allele
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: TYR rs1042602-A allele
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: SLC45A2 rs1126809-A allele
Number of subjects: 795
Study: 35322474

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (20 mL of 0.375% ropivacaine and 0.5 mcg/kg of clonidine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal morphine (150 mcg preservative-free morphine with 2 mL of normal saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal morphine
Number of subjects: 60
Study: 33065448

Group type: EXPERIMENTAL
Intervention: Cognitive-motor intervention
Number of subjects: 176
Study: 34193498

Group type: EXPERIMENTAL
Intervention: 100% platelet-rich plasma (APRP) eye drops for 4 weeks
Number of subjects: 130

Group type: COMPARATOR
Intervention: 100% serum (AS) eye drops for 4 weeks
Number of subjects: 130
Study: 32492824

Group type: EXPERIMENTAL
Intervention: ACE pilot trial
Number of subjects: 38
Study: 35751568

Group type: EXPERIMENTAL
Intervention: Estimands framework for factorial trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment for other factors in noncollapsible effect measures
Number of subjects: 0
Study: 32718922

Group type: EXPERIMENTAL
Intervention: Care Coordination Redesign (CCR)
Number of subjects: 933

Group type: COMPARATOR
Intervention: Care Coordination Programme (CCP)
Number of subjects: 933
Study: 35977994

Group type: EXPERIMENTAL
Intervention: Eye-tracking Training
Number of subjects: 53

Group type: COMPARATOR
Intervention: After-school remediation class
Number of subjects: 53
Study: 34048275

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) and hematopoietic stem cell transplant (HSCT)
Number of subjects: 215